WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year olds

The World Health Organization's advisory panel on Friday recommended extending the use of and German Partner BioNTech's COVID-19 vaccine to include children aged 5 to 11 years old.

The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday to evaluate the companies' vaccine. The vaccine is currently recommended for use in people aged 12 years and above.